TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
ARCT

Arcturus Therapeutics Holdings Inc

Healthcare · Biotechnology

16.00$ -5.3% vs. previous close Closing price · As of: Sep 18, 2026

Ownership

Ownership Structure

Who owns Arcturus Therapeutics Holdings Inc (ARCT)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 92.0% of the shares are freely tradable; institutional investors hold 80.3%.

Institutional ownership ?Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings. 80.3%
Insiders ?Share of the stock held by the executives, founders and major shareholders of the company itself. 8.0%
Float ?Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders. 92.0%
Short % of float ?Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices. 26.7%
Shares Outstanding ?Total number of shares issued. Price times share count gives market cap. 28Mio.

Largest Shareholders

Institutions

Institutions ARCT
Name Stake (%) Shares Change (%) Date
Federated Hermes Inc 11.62 3,303,640 +0.0 06/30/2026
ARK Investment Management LLC 9.74 2,769,518 +6.1 03/31/2026
BlackRock Inc 9.19 2,613,281 -0.2 03/31/2026
Sumitomo Mitsui Trust Group Inc 6.91 1,963,123 -14.2 06/30/2026
Amova Asset Management Americas, Inc 6.90 1,960,458 -14.4 06/30/2026

Funds

Funds ARCT
Name Stake (%) Shares Change (%) Date
ARK Genomic Revolution ETF 10.22 2,904,131 -0.3 08/31/2026
ARK Genomic Revolution 9.69 2,754,707 +4.6 06/30/2026
Federated Hermes Kaufmann R 7.29 2,072,500 +0.0 06/30/2026
Federated Hermes Kaufmann Growth 7.29 2,072,500 +0.0 06/30/2026
Amova ARK Pstv Chg Innovt P JPY Acc 5.65 1,604,742 -7.0 07/31/2026

Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?